Printed From:

Lantus® is a once-daily, long-acting insulin that provides glycemic control for 24 hours with no pronounced peak.1

Lantus® demonstrated safe and effective glycemic control in patients with diabetes as part of an overall diabetes treatment plan, including diet, exercise, and other diabetes medications.

A1C reduction2

See the data

Glycemic Control1,3

See the data

CV safety and A1C reductions1,4

See the data

Lantus® is a basal insulin with long-term (6.2 years) CV safety data4,a

a Including CV death, nonfatal Ml, nonfatal stroke, revascularization, or hospitalization for heart failure

Read more
 

Learn more about our $0* co-pay and coverage

* Eligibility restrictions apply.

 

References

  1. Lantus® Prescribing Information. August 2015.
  2. Rosenstock J, Davies M, Home PD, et al. Diabetologia. 2008;51:408-416.
  3. Data on file, Sanofi U.S.
  4. ORIGIN Trial Investigators. N Eng J Med. 2012;367(4):319-328.